Posterior ischemic optic neuropathy as a complication of Moyamoya syndrome in a 36-year-old male with sickle cell anemia
Keywords:
Posterior ischemic optic neuropathy; Sickle cell disease; Moyamoya syndrome; Computed tomography angiography; Magnetic resonance angiographyAbstract
Purpose: To describe a unique case of posterior ischemic optic neuropathy (PION) in a 36-year-old man with sickle cell disease (SCD) and Moyamoya syndrome (MMS), highlighting the rare and complex interaction of these conditions and their implications in ocular ischemic events.
Case Report: A North African male with homozygous SCD presented with sudden, painless diminution of vision in his left eye, two months before consulting in our department. On examination, his visual acuity was preserved in the right eye but limited to counting fingers at one meter in the left eye. A significant left relative afferent pupillary defect was noted. Funduscopic examination and Fluorescein angiography showed signs of proliferative sickle cell retinopathy, with optic disc atrophy in the left eye. Computed tomography angiography and magnetic resonance angiography of the brain confirmed MMS with stenosis of the internal carotid artery and Moyamoya vessel formation, as well as optic nerve atrophy. No recovery in visual acuity was observed one year later.
Conclusion: This case is notable for the unusual coexistence of SCD, MMS, and PION in the same patient. It also highlights the complexity of managing coexisting SCD and MMS, as both conditions amplify the risk of cerebral and ocular ischemic events, leading to irreversible vision loss. Multidisciplinary care is essential to monitor and address the diverse manifestations of these overlapping conditions and prevent severe outcomes.
Publication and Publisher Transfer Disclaimer: This article was originally published by WisdomGale Publishing, having its registered address at 14 Rue de Grand-Bigard, 1082 Brussels, Belgium. Following the formal transfer of publication rights and the subsequent change of publisher, the article was migrated to the publishing platform of International Medical Publishing Group (IMPG), India. The original publication details, authorship, and scholarly content remain unchanged. All subsequent publication management and archival responsibilities are administered by IMPG, India, in accordance with the terms and conditions of the publisher transfer agreement.




